[Ophthalmoplegia plus: a clinico-metabolic study (author's transl)].
D000293:Adolescent; D000328:Adult; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D003638:Deafness / Q000209:etiology; D003680:Deglutition Disorders / Q000209:etiology; D005121:Extremities; D005947:Glucose / Q000378:metabolism; D006327:Heart Block / Q000209:etiology; D006801:Humans; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000378:metabolism; D008297:Male; D009135:Muscular Diseases / Q000150:complications* / Q000378:metabolism; D009438:Neuraminic Acids / Q000378:metabolism; D009886:Ophthalmoplegia / Q000209:etiology / Q000378:metabolism; D010523:Peripheral Nervous System Diseases / Q000150:complications; D013064:Speech Disorders / Q000209:etiology
D002556:Cerebrospinal Fluid Proteins; D008074:Lipoproteins; D009438:Neuraminic Acids; D005947:Glucose
Oftalmoplegia plus: studio clinico-metabolico